Articles

Around the world, toxoplasmosis is a significant zoonotic parasite illness. Toxoplasma gondii preferentially infects central nervous system tissues in immune-competent people, which may contribute to some psychiatric conditions. The development of methods to manage the illness, lessen parasite transmission, and restrict environmental pollution has been aided by knowledge of the parasite's life cycle, transmission, risk groups, and responses of the host. Inorganic gold and silver nanoparticles can alter cellular apoptosis in response to Toxoplasma gondii infection. NPs have been gaining popularity for their usage in drug delivery, therapeutics, and diagnostics among others. Furthermore, studies have demonstrated that NPs, such as gold and silver nanoparticles, can induce apoptosis in a range of cell types. The results are novel and advance our knowledge of how nanoparticles interact with cells. Due to issues with drug delivery, side effects, and drug resistance, traditional treatment approaches frequently have limits. Nanotechnology has shown promise in recent years as a means of overcoming these obstacles and transforming the management of parasitic illnesses.